<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-24303" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Biochemistry, Lipase</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Pirahanchi</surname>
            <given-names>Yasaman</given-names>
          </name>
          <aff>California Northstate College Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sharma</surname>
            <given-names>Sandeep</given-names>
          </name>
          <aff>Mery Fitzgerald Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Yasaman Pirahanchi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sandeep Sharma declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>26</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-24303.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Lipases are a family of enzymes that break down triglycerides into free fatty acids and glycerol. There are expressed and active in multiple tissues; for example, hepatic lipases are in the liver, hormone-sensitive lipases are in adipocytes, lipoprotein lipase is in the vascular endothelial surface, and pancreatic lipase is in the small intestine. <xref ref-type="bibr" rid="article-24303.r1">[1]</xref>&#x000a0;Lipases in pancreatic secretions are responsible for digestion and hydrolysis of fat and absorption of fat-soluble vitamins. Understanding the lipase function is crucial for the pathophysiology of fat necrosis and acute and chronic pancreatitis. Also, lipases play an essential role in the mechanism of some cholesterol-lowering&#x000a0;medications. This review will explore the lipase enzyme's function, pathophysiology, and clinical significance.<xref ref-type="bibr" rid="article-24303.r2">[2]</xref></p>
      </sec>
      <sec id="article-24303.s2" sec-type="Molecular Level&#x0000d;&#x0000a;">
        <title>Molecular Level
</title>
        <p>The lipases belong to the alpha/beta-hydrolase fold superfamily of enzymes. They work by employing chymotrypsin-like hydrolysis, which uses a histidine base, a serine nucleophile,&#x000a0;and aspartic acid.<xref ref-type="bibr" rid="article-24303.r3">[3]</xref><xref ref-type="bibr" rid="article-24303.r4">[4]</xref></p>
      </sec>
      <sec id="article-24303.s3" sec-type="Function">
        <title>Function</title>
        <p>Lipase is an enzyme that breaks down triglycerides into free fatty acids and glycerol by catalyzing the hydrolysis of the ester bonds in triglycerides.<xref ref-type="bibr" rid="article-24303.r5">[5]</xref>&#x000a0;Lipases are present in pancreatic secretions and participate in fat digestion and metabolism. They play an essential role in lipid transport and serve individual functions in several tissues, including hepatic lipase in the liver, hormone-sensitive lipases in the adipocytes, lipoprotein lipase in the endothelial cells, and pancreatic lipase in the small intestine. Hepatic lipase in the liver&#x000a0;degrades&#x000a0;the triglycerides that remain in intermediate-density lipoprotein (IDL).&#x000a0;Hormone-sensitive lipase is found&#x000a0;within fat tissue and&#x000a0;is responsible for hydrolyzing the triglycerides stored&#x000a0;within adipocytes.&#x000a0;Lipoprotein lipase is found in the vascular endothelial cells and&#x000a0;is responsible for degrading&#x000a0;triglycerides that circulate from chylomicrons and very low-density lipoproteins (VLDLs).&#x000a0;Pancreatic lipase is found&#x000a0;within the small intestine and&#x000a0;is involved in degrading&#x000a0;dietary triglycerides.<xref ref-type="bibr" rid="article-24303.r6">[6]</xref>&#x000a0;</p>
        <p>The LDL ultimately serves to transport cholesterol from the liver to peripheral tissue. Hepatic lipase plays a crucial role in developing and delivering low-density lipoprotein (LDL). The LDL&#x000a0;is formed by modifying the IDL in the peripheral tissue and liver by hepatic lipase. These LDL particles are taken up, or endocytosed, via receptor-mediated endocytosis by target cell tissue. The LDL ultimately serves to transport cholesterol from the liver to peripheral tissue.<xref ref-type="bibr" rid="article-24303.r7">[7]</xref></p>
      </sec>
      <sec id="article-24303.s4" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Fat necrosis can generally result from non-enzymatic and enzymatic cellular processes. During traumatic events, such as physical injury in breast tissue, non-enzymatic fat necrosis takes place.<xref ref-type="bibr" rid="article-24303.r8">[8]</xref> In acute pancreatitis, saponification of peripancreatic fat occurs. This is due to the damage to fat cells causing the release of lipase, triglyceride breakdown, and the release of fatty acids. These fatty acids are charged negatively, and once released in the bloodstream, they bind to positively charged calcium ions. This process of salt formation between negatively charged fatty acids and positively charged calcium ions is called saponification.<xref ref-type="bibr" rid="article-24303.r9">[9]</xref>&#x000a0;Histologically, saponified cells appear as dead fat cells outlining the tissue, which do not contain peripheral nuclei. The saponification of the fatty acid and calcium ion combined on hematoxylin and eosin staining appears dark blue.<xref ref-type="bibr" rid="article-24303.r10">[10]</xref></p>
      </sec>
      <sec id="article-24303.s5" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>High levels of serum lipase&#x000a0;may be indicative of pancreatitis. In the case of acute pancreatitis, diagnosis is based on the lab results with two of the three criteria. The criteria used for diagnosis include acute epigastric pain radiating to the back, increased serum amylase, or increased lipase levels, which are up to three times the upper limit of normal serum lipase levels. The latter is a more specific diagnostic marker than amylase&#x000a0;or imaging with CT or MRI. Acute pancreatitis is due to autodigestion of the pancreas by pancreatic enzymes, causing surrounding edema in the pancreas.</p>
        <p>The common causes of this pathology include excessive ethanol use, gallstones, trauma, mumps, steroids, autoimmune disease, hypertriglyceridemia with levels above 1000 mg/dL, hypercalcemia, ERCP, scorpion sting, and drugs such as nucleoside reverse transcriptase inhibitors, protease inhibitors, and sulfa drugs. Acute pancreatitis can lead to complications including pseudocyst, in which the pancreatic lining is composed of granulation tissue rather than epithelium, necrosis, abscess, infection, hemorrhage, hypocalcemia due to precipitation of calcium soaps, shock, and organ failures such as acute respiratory distress syndrome and renal failure.<xref ref-type="bibr" rid="article-24303.r11">[11]</xref></p>
        <p>Elevated serum levels of lipase and amylase may or may not be present in chronic pancreatitis, in contrast to acute pancreatitis, where serum lipase is almost always elevated. Chronic pancreatitis is due to chronic inflammation, calcification, and atrophy of the pancreas. The primary causes of chronic pancreatitis include chronic alcohol abuse in adults and genetic predispositions such as cystic fibrosis in children. The complications of chronic pancreatitis include deficiency of pancreatic enzymes and the formation of pseudocysts. Pancreatic insufficiency usually occurs when there is less than ten percent of pancreatic function remaining due to a deficiency in pancreatic enzymes contained within the pancreas to digest fats such as lipase. This pancreatic enzyme deficiency leads to clinical manifestations of steatorrhea, as fat is not absorbed properly in the small intestine and is instead excreted. The inability to absorb fats appropriately can manifest as fat-soluble vitamin (vitamins A, D, E, and K) deficiency. Pancreatic insufficiency can also lead to diabetes mellitus due to&#x000a0;insufficient insulin release from pancreatic tissue.<xref ref-type="bibr" rid="article-24303.r12">[12]</xref>&#x000a0; &#x000a0;</p>
        <p>Clinically, orlistat is a medication used for weight loss that acts on lipase. Specifically, this medication inhibits pancreatic and gastric lipases. This inhibition of the lipases leads to the reduced breakdown and absorption of dietary fats. This can lead to side effects due to decreased absorption of fats, such as reduced absorption of fat-soluble vitamins. Other side effects include abdominal pain, frequent bowel movements, bowel urgency, and flatulence.<xref ref-type="bibr" rid="article-24303.r13">[13]</xref></p>
        <p>Some cholesterol-lowering drugs act on lipases. Fibrates, such as bezafibrate, gemfibrozil, and fenofibrate, work by activating peroxisome proliferator-activated receptor alpha (PPAR-alpha) and upregulating lipoprotein lipase (LpL), which leads to a decrease in serum triglyceride levels along with induction of increased synthesis of HDL. Fibrates are clinically indicated primarily for lowering triglycerides.&#x000a0;Side effects of fibrates include cholesterol gallstones, rhabdomyolysis, mainly if used with statins, and increased LDL.<xref ref-type="bibr" rid="article-24303.r14">[14]</xref></p>
        <p>Niacin, or vitamin B3, is another cholesterol-lowering medication that acts on lipase. Specifically, niacin inhibits hormone-sensitive lipase, leading to inhibition of VLDL synthesis in the liver. Niacin is clinically indicated primarily for increasing HDL levels. The side effects are erythema and flushing of the upper body, increased glucose levels, increased uric acid levels, acanthosis nigricans, and pruritus.<xref ref-type="bibr" rid="article-24303.r15">[15]</xref></p>
      </sec>
      <sec id="article-24303.s6">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24303&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24303">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/24303/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=24303">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-24303.s7">
        <title>References</title>
        <ref id="article-24303.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holmes</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Cox</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>VandeBerg</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Comparative studies of mammalian acid lipases: Evidence for a new gene family in mouse and rat (Lipo).</article-title>
            <source>Comp Biochem Physiol Part D Genomics Proteomics</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>5</volume>
            <issue>3</issue>
            <fpage>217</fpage>
            <page-range>217-26</page-range>
            <pub-id pub-id-type="pmid">20598663</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24303.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cerk</surname>
                <given-names>IK</given-names>
              </name>
              <name>
                <surname>Wechselberger</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Oberer</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Adipose Triglyceride Lipase Regulation: An Overview.</article-title>
            <source>Curr Protein Pept Sci</source>
            <year>2018</year>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>221</fpage>
            <page-range>221-233</page-range>
            <pub-id pub-id-type="pmid">28925902</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24303.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lenfant</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hotelier</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Velluet</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bourne</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Marchot</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chatonnet</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>ESTHER, the database of the &#x003b1;/&#x003b2;-hydrolase fold superfamily of proteins: tools to explore diversity of functions.</article-title>
            <source>Nucleic Acids Res</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>41</volume>
            <issue>Database issue</issue>
            <fpage>D423</fpage>
            <page-range>D423-9</page-range>
            <pub-id pub-id-type="pmid">23193256</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24303.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holmquist</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Alpha/Beta-hydrolase fold enzymes: structures, functions and mechanisms.</article-title>
            <source>Curr Protein Pept Sci</source>
            <year>2000</year>
            <month>Sep</month>
            <volume>1</volume>
            <issue>2</issue>
            <fpage>209</fpage>
            <page-range>209-35</page-range>
            <pub-id pub-id-type="pmid">12369917</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24303.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salah</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Mosbah</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fendri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gargouri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gargouri</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Mejdoub</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Biochemical and molecular characterization of a lipase produced by Rhizopus oryzae.</article-title>
            <source>FEMS Microbiol Lett</source>
            <year>2006</year>
            <month>Jul</month>
            <volume>260</volume>
            <issue>2</issue>
            <fpage>241</fpage>
            <page-range>241-8</page-range>
            <pub-id pub-id-type="pmid">16842350</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24303.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Waldmann</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Parhofer</surname>
                <given-names>KG</given-names>
              </name>
            </person-group>
            <article-title>Apheresis for severe hypercholesterolaemia and elevated lipoprotein(a).</article-title>
            <source>Pathology</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>51</volume>
            <issue>2</issue>
            <fpage>227</fpage>
            <page-range>227-232</page-range>
            <pub-id pub-id-type="pmid">30611543</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24303.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lotta</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Sharp</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Day</surname>
                <given-names>FR</given-names>
              </name>
              <name>
                <surname>Burgess</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Luan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bowker</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Cai</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wittemans</surname>
                <given-names>LBL</given-names>
              </name>
              <name>
                <surname>Kerrison</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Khaw</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>McCarthy</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>O'Rahilly</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Savage</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>JRB</given-names>
              </name>
              <name>
                <surname>Langenberg</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wareham</surname>
                <given-names>NJ</given-names>
              </name>
            </person-group>
            <article-title>Association of Genetically Enhanced Lipoprotein Lipase-Mediated Lipolysis and Low-Density Lipoprotein Cholesterol-Lowering Alleles With Risk of Coronary Disease and Type 2 Diabetes.</article-title>
            <source>JAMA Cardiol</source>
            <year>2018</year>
            <month>Oct</month>
            <day>01</day>
            <volume>3</volume>
            <issue>10</issue>
            <fpage>957</fpage>
            <page-range>957-966</page-range>
            <pub-id pub-id-type="pmid">30326043</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24303.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vasei</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Shishegar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ghalkhani</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Darvishi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Fat necrosis in the Breast: A systematic review of clinical.</article-title>
            <source>Lipids Health Dis</source>
            <year>2019</year>
            <month>Jun</month>
            <day>11</day>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>139</fpage>
            <pub-id pub-id-type="pmid">31185981</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24303.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aloysius</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Carvajal</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Slizyte</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Skorve</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Berge</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Bj&#x000f8;rndal</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Chicken Protein Hydrolysates Have Anti-Inflammatory Effects on High-Fat Diet Induced Obesity in Mice.</article-title>
            <source>Medicines (Basel)</source>
            <year>2018</year>
            <month>Dec</month>
            <day>28</day>
            <volume>6</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">30597839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24303.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prieto Vidal</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Adeseun Adigun</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Pham</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Mumtaz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Manful</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Callahan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Keough</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>The Effects of Cold Saponification on the Unsaponified Fatty Acid Composition and Sensory Perception of Commercial Natural Herbal Soaps.</article-title>
            <source>Molecules</source>
            <year>2018</year>
            <month>Sep</month>
            <day>14</day>
            <volume>23</volume>
            <issue>9</issue>
            <pub-id pub-id-type="pmid">30223479</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24303.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ismail</surname>
                <given-names>OZ</given-names>
              </name>
              <name>
                <surname>Bhayana</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Lipase or amylase for the diagnosis of acute pancreatitis?</article-title>
            <source>Clin Biochem</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>50</volume>
            <issue>18</issue>
            <fpage>1275</fpage>
            <page-range>1275-1280</page-range>
            <pub-id pub-id-type="pmid">28720341</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24303.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oh</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Kwon</surname>
                <given-names>CI</given-names>
              </name>
              <name>
                <surname>El Hajj</surname>
                <given-names>II</given-names>
              </name>
              <name>
                <surname>Easler</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Watkins</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fogel</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>McHenry</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sherman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zimmerman</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Lehman</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>Low Serum Pancreatic Amylase and Lipase Values Are Simple and Useful Predictors to Diagnose Chronic Pancreatitis.</article-title>
            <source>Gut Liver</source>
            <year>2017</year>
            <month>Nov</month>
            <day>15</day>
            <volume>11</volume>
            <issue>6</issue>
            <fpage>878</fpage>
            <page-range>878-883</page-range>
            <pub-id pub-id-type="pmid">29081212</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24303.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pamuk</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Yilmaz</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kebap&#x000e7;ilar</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kirbiyik</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Alacacio&#x0011f;lu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bozkaya</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pamuk</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Demirpence</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The effect of orlistat and weight loss diet on plasma ghrelin and obestatin.</article-title>
            <source>J Res Med Sci</source>
            <year>2018</year>
            <volume>23</volume>
            <fpage>95</fpage>
            <pub-id pub-id-type="pmid">30595703</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24303.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>In&#x000e1;cio</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Rafacho</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>de Paula Camaforte</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Teixeira</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vareda</surname>
                <given-names>PMP</given-names>
              </name>
              <name>
                <surname>Violato</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Bosqueiro</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Prevention of Elevation in Plasma Triacylglycerol with High-Dose Bezafibrate Treatment Abolishes Insulin Resistance and Attenuates Glucose Intolerance Induced by Short-Term Treatment with Dexamethasone in Rats.</article-title>
            <source>Int J Endocrinol</source>
            <year>2018</year>
            <volume>2018</volume>
            <fpage>3257812</fpage>
            <pub-id pub-id-type="pmid">30532777</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24303.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sanghera</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Pharmacological Options in Atherosclerosis: A Review of the Existing Evidence.</article-title>
            <source>Cardiol Ther</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>5</fpage>
            <page-range>5-20</page-range>
            <pub-id pub-id-type="pmid">30543029</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
